The Lab
A wet-lab a founder walks into, and a venture fund on the floor above.
In the city the Prophet ﷺ called Tayyibah — the wholesome — the world has never built a single biotech lab. We are building the first.
Saudi Arabia has committed $34.6 billion of non-oil GDP and eleven thousand jobs to biotechnology by 2040. The factories are being built. The capital is being committed. The labs that turn ideas into companies are not.
Every founder in the Kingdom with a thesis written on the back of an envelope still has to leave to start a company. The biomanufacturing plants that the strategy is building will need a constant feed of new molecules and new platforms. Today there is no domestic source.
One campus on the edge of Madinah, organised around four reinforcing engines. The wet-lab a founder walks into. The venture fund that capitalises her. The contract-research bench her company commissions. The platform that introduces her to the world. Each one returns capital on its own. Together they compound.
A wet-lab a founder walks into, and a venture fund on the floor above.
Sixty thousand square metres of campus. The room every tenant secretly wants.
Clinical research and biomanufacturing pilots — recurring revenue from day one.
The conference, the fellowships, the editorial — how the world finds Madinah.
$100M
Equity we are raising for first close
60,000 m²
Of campus, on Madinah's edge
$34.6B
The Kingdom's biotech GDP commitment, 2040
Oct 2026
When the first close is taken
It was here that Al-Shifa bint Abdullah — whose name means healing — taught the first generation of Muslims medicine, reading, and writing. The Madinah Knowledge Economic City masterplan already designates biotechnology as a pillar. And under the special-economic-zone framework administered by ECZA, foreign capital can — for the first time — hold equity in a project of this scale on this land.
The place, in fullFour days in Madinah, by invitation. The unveiling of the masterplan, the founders, and the people writing the first cheques.